That's because the goal of the company was to evaluate the use of nirogacestat for the treatment of adults with relapsed/refractory ovarian granulosa cell tumors (OvGCTs) in a phase 2 open-label ...

The drug is also in mid-stage clinical development for ovarian granulosa cell tumors, a rare type of ovarian cancer that currently has no FDA-approved therapies. Through partnerships, the twice ...

is also in Phase 2 clinical development as a monotherapy for the treatment of ovarian granulosa cell tumors (GCT), a subtype of ovarian cancer. Shares of NASDAQ:SWTX traded down $0.21 during ...

In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...

In a preclinical study, Cedars-Sinai investigators have demonstrated how age-related changes to cells surrounding a tumor ...

Experiments in mice suggested that monoclonal antibodies targeting cell-surface NPM1 might be effective against certain solid tumors, including prostate and colorectal cancer. "Finding cell-surface ...

It wasn't until an intravaginal scan at 15 that doctors found the cyst, later confirmed as a dermoid cyst - a benign tumour that can contain hair, teeth, and skin tissue. Alongside the cyst ...

Savannah Stuthers, 20, "nearly vomited" when she saw pictures of the teratoma, and she felt horrified to learn what was ...

In contrast, this dendritic cell-based immunotherapy aims to induce a new, specific immune response against the tumor." Describing the strategy, study co-supervisor Stefanie Wculek—formerly at ...